GIBSON LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
GIBSON LABORATORIES, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TRI-VALENT. The owner is based in LAGUNA HILLS, CA.
23192 VERDUGO
STE. D
LAGUNA HILLS, CA 92653
Showing of trademarks Trademarks
Trademark Classifications
GIBSON LABORATORIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GIBSON LABORATORIES, INC. have?
GIBSON LABORATORIES, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does GIBSON LABORATORIES, INC. file in?
GIBSON LABORATORIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GIBSON LABORATORIES, INC.'s most well-known trademarks?
GIBSON LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as TRI-VALENT. These are among 1 currently registered trademark in the portfolio.
What is GIBSON LABORATORIES, INC.'s trademark registration success rate?
GIBSON LABORATORIES, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.